AUCKLAND: Pacific Edge Limited announced the appointment of Demi Stefanova as Chief Operating Officer, effective from 21 June 2021.
This is a new role for Pacific Edge as the company strengthens its leadership team to meet the demands of the business as it grows.
Pacific Edge is focused on leveraging recent milestones to drive continued commercial adoption of its family of Cxbladder bladder cancer diagnostic tests in its targeted markets, particularly the United States.
The COO will have responsibility for global manufacturing and compliance functions, and in particular, the manufacturing and operational goals and tactical plans for maximising operational efficiency, optimising production levels and driving operational excellence, while at the same time ensuring that the company meets and exceeds customer expectations.
Demi is a senior executive with a wealth of experience establishing and running manufacturing operations in highly regulated environments. She has specific experience in Cancer Medical Research Operations, Biotechnology, Supply Chain & Logistics and Pharmaceutical and GMP Engineering.
Demi has worked for a number of global businesses, executing global change and transformation programmes.
Demi has held senior leadership roles since 2004. Her most recent role was as Head of Operations of the Children Medical Research Institute in Australia. Previous to this, her roles included Program Director – Executive Strategy Delivery for Firmenich SA in Switzerland; and Program Manager – APAC Network Transformation for Caterpillar in Australia.